Vivos Inc. (OTCQB: RDGL) is a medical device company on the forefront of changing the way cancer is treated with its patented Precision Radionuclide Therapy™.
Also known as PRnT™, the treatment uses highly localized radiation to destroy cancerous tumors by placing a radioactive isotope directly inside the treatment area, delivering therapeutic radiation from within the tumor. Vivos Inc. has developed a Yttrium-90 based injectable device to treat tumors in animals (IsoPet® Division) and humans (RadioGel™ Division, not currently approved for human use).
IsoPet® is an internationally registered trademark of Vivos Inc.
IsoPet® is a international registered trademark of Vivos, Inc. (OTCQB:RDGL)
Copyright © 2023 Vivos, Inc. - All Rights Reserved